Pharmaceuticals, Biotechnology and Life Sciences
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW) ,…
BioLegacy’s New Vancouver Hub Drives Innovation in Opioid Crisis Solutions with Unmatched Manufacturing and Research CapabilitiesVANCOUVER, British Columbia, Sept. 23,…
KEY LARGO, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) — Remedy’s Nutrition®, a trusted natural dietary supplement company since 1972 and…
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for…
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative…
DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO),…
CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the…
Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May…
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of…